Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, and Lung Cancer Diagnosis and Treatment.
Comprehensive transcriptomic and proteomic analysis reveals biological changes and potential regulatory mechanisms of endothelial cells under heat stress conditions
Effect of corticosubcortical iron deposition on dysfunction in CADASIL is mediated by white matter microstructural damage
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Considerations for treatment duration in responders to immune checkpoint inhibitors
Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer
Myeloid-Derived Growth Factor Promotes Intestinal Glucagon-Like Peptide-1 Production in Male Mice With Type 2 Diabetes
Postoperative complications and quality of life in patients with pituitary adenoma
Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer
Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989–2012: a matched case–control study
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity